- 恒指
- 25,277
- -223
- 大市成交 3,425億
- 力生製藥
- 21.790-1.060 (-4.639%)
盈利能力分析
- 7.613
- 3.815
- 7.821
- 2.137
- 2.803
- 6.334
- 3.191
- 6.536
- 1.786
- 2.391
- 7.164
- 3.593
- 7.403
- 2.025
- 2.651
邊際利潤分析
- 57.820
- 55.068
- 59.398
- 57.589
- 58.379
- 44.278
- 16.589
- 36.409
- 10.297
- 12.538
- 38.382
- 12.899
- 31.270
- 4.449
- 4.579
- 37.158
- 13.918
- 31.381
- 8.164
- 11.182
收益指標分析
- 31.463
- 57.713
- 43.668
- 124.283
- 94.316
- 74.349
- 47.733
- 3.837
- 20.244
- 14.037
- -2.999
- -2.640
- 0.097
- 0.253
- 0.155
償債能力分析
- 4.622
- 4.099
- 4.501
- 3.597
- 4.265
- 4.314
- 3.798
- 4.219
- 3.324
- 3.851
- 15.501
- 17.035
- 15.174
- 17.797
- 15.034
- 0.892
- 1.716
- 0.425
- 0.834
- 0.175
- 10,603.537
- 5,455.405
- 22,287.935
- 11,341.693
- 54,114.921
- 541.436
- 483.992
- 559.003
- 461.884
- 565.143
- -8.333
- -3.954
- -6.044
- -0.757
- -0.574
營運能力分析
- 62.464
- 34.041
- 25.410
- 41.029
- 46.233
- 137.935
- 120.123
- 144.350
- 158.398
- 184.941
大國博弈
2026-27年度財政預算案
More